These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1827801)

  • 1. Contact dermatitis in reaction to 2% topical minoxidil solution.
    Wilson C; Walkden V; Powell S; Shaw S; Wilkinson J; Dawber R
    J Am Acad Dermatol; 1991 Apr; 24(4):661-2. PubMed ID: 1827801
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitization for external treatment with minoxidil].
    van Joost T
    Ned Tijdschr Geneeskd; 1988 Jun; 132(25):1141-2. PubMed ID: 3398938
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergic contact dermatitis from minoxidil.
    Ebner H; Müller E
    Contact Dermatitis; 1995 May; 32(5):316-7. PubMed ID: 7634798
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment.
    Friedman ES; Friedman PM; Cohen DE; Washenik K
    J Am Acad Dermatol; 2002 Feb; 46(2):309-12. PubMed ID: 11807448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pustular dermatosis of the scalp due to topical minoxidil 5.
    El Anzi O; Hassam B
    Pan Afr Med J; 2018; 30():83. PubMed ID: 30344867
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
    Hagemann T; Schlütter-Böhmer B; Allam JP; Bieber T; Novak N
    Contact Dermatitis; 2005 Jul; 53(1):53-5. PubMed ID: 15982234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical minoxidil sensitization in androgenic alopecia.
    van der Willigen AH; Dutrée-Meulenberg RO; Stolz E; Geursen-Reitsma AM; van Joost T
    Contact Dermatitis; 1987 Jul; 17(1):44-5. PubMed ID: 2958212
    [No Abstract]   [Full Text] [Related]  

  • 8. Pigmented contact dermatitis from topical minoxidil 5%.
    Trattner A; David M
    Contact Dermatitis; 2002 Apr; 46(4):246. PubMed ID: 12081710
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia.
    Sinclair RD; Mallari RS; Tate B
    Australas J Dermatol; 2002 Nov; 43(4):311-2. PubMed ID: 12423443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical minoxidil dose-response effect in alopecia areata.
    Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
    Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic contact dermatitis from minoxidil.
    Alomar A; Smandia JA
    Contact Dermatitis; 1988 Jan; 18(1):51-2. PubMed ID: 3349780
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact dermatitis to minoxidil.
    Tosti A; Bardazzi F; De Padova MP; Caponeri GM; Melino M; Veronesi S
    Contact Dermatitis; 1985 Oct; 13(4):275-6. PubMed ID: 4085233
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical minoxidil therapy for hereditary male pattern alopecia.
    Roenigk HH; Pepper E; Kuruvilla S
    Cutis; 1987 Apr; 39(4):337-42. PubMed ID: 3556042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2% topical minoxidil solution in male-pattern baldness: preliminary European results.
    Civatte J; Laux B; Simpson NB; Vickers CF
    Dermatologica; 1987; 175 Suppl 2():42-9. PubMed ID: 3319731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients.
    Scheman AJ; West DP; Hordinksy MK; Osburn AH; West LE
    Contact Dermatitis; 2000 Apr; 42(4):241. PubMed ID: 10750861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.